scispace - formally typeset
A

Annette Balle Sørensen

Researcher at Aarhus University

Publications -  28
Citations -  668

Annette Balle Sørensen is an academic researcher from Aarhus University. The author has contributed to research in topics: Murine leukemia virus & Provirus. The author has an hindex of 15, co-authored 28 publications receiving 644 citations.

Papers
More filters
Journal ArticleDOI

Amplification and sequence analysis of DNA flanking integrated proviruses by a simple two-step polymerase chain reaction method.

TL;DR: A two-step polymerase chain reaction method that can be used for the amplification of cellular DNA sequences adjacent to an integrated retroviral provirus and should be generally useful to analyze DNA sequences either upstream or downstream from a known sequence.
Journal ArticleDOI

Septin9 is involved in septin filament formation and cellular stability.

TL;DR: The importance of Sept9 for septin filament formation and general cell stability is revealed as well as the consequences of homozygous loss ofSept9 in immortalized murine embryonic fibroblasts.
Journal ArticleDOI

Sequence tags of provirus integration sites in dnas of tumors induced by the murine retrovirus sl3-3

TL;DR: The murine retrovirus SL3-3 is a potent inducer of T-cell lymphomas when inoculated into susceptible newborn mice and its integrations, including the known common integration site c-myc as well as genes not previously identified as targets of provirus integration, are found to be clonal.
Journal ArticleDOI

Sint1, a Common Integration Site in SL3-3-Induced T-Cell Lymphomas, Harbors a Putative Proto-Oncogene with Homology to the Septin Gene Family

TL;DR: Findings raise the possibility that a proto-oncogene belonging to the septin family, and located about 15 kb upstream of the provirus integration sites, is involved in murine leukemia virus-induced T-cell lymphomagenesis.
Journal ArticleDOI

Expression level, tissue distribution pattern, and prognostic impact of vascular endothelial growth factors VEGF and VEGF-C and their receptors Flt-1, KDR, and Flt-4 in different subtypes of non-Hodgkin lymphomas.

TL;DR: Investigating the expression of angio- and lymphangiogenic molecules in non-Hodgkin lymphomas treated in the pre-rituximab era found that diffuse intratumoral VEGF staining correlated with shorter overall survival (OS) and diffuse KDR staining was associated with a higher risk of histologic transformation.